1-10 of 10
Martin Pruschy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2887: Impact of ionizing radiation on the energy metabolism of normal and tumor cells in the brain

Marvin Kreuzer, Pascal Imseng, Bruno Weber, Martin Pruschy
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2887.
https://doi.org/10.1158/1538-7445.AM2024-2887
Published: 22 March 2024
View article titled, Abstract 2887: Impact of ionizing radiation on the energy metabolism of normal and tumor cells in the brain
Journal Articles

Abstract 2879: Spatiotemporal fractionation: An innovative concept of fractionated radiotherapy

Irene Vetrugno, Irma Telarovic, Nathan Torelli, Jan Unkelbach, Martin Pruschy
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2879.
https://doi.org/10.1158/1538-7445.AM2024-2879
Published: 22 March 2024
View article titled, Abstract 2879: Spatiotemporal fractionation: An innovative concept of fractionated radiotherapy
Journal Articles

Abstract 704: Targeting hypoxic survival pathways to overcome radiotherapy-related treatment resistance

Claire Beckers, Lazaros Vasilikos, Alba Sanchez-Fernandez, Lorena Moor, Martin Pruschy
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 704.
https://doi.org/10.1158/1538-7445.AM2024-704
Published: 22 March 2024
View article titled, Abstract 704: Targeting hypoxic survival pathways to overcome radiotherapy-related treatment resistance
Journal Articles

Abstract B1: Radiotherapy promotes tumor-specific effector CD8+ T cells via DC activation.

Anurag K. Gupta, Hans Christian Probst, Van Vuong, Alexandro Landshammer, Sabine Muth, Hideo Yagita, Reto Schwendener, Martin Pruschy, Alexander Knuth, Maries van den Broek
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): B1.
https://doi.org/10.1158/1538-7445.TUMIMM2012-B1
Published: 02 April 2014
View article titled, Abstract B1: Radiotherapy promotes tumor-specific effector CD8+ T cells via DC activation.
Journal Articles

Abstract 1347: BAL101553: An optimized prodrug of the microtubule destabilizer BAL27862 with superior antitumor activity

Jens Pohlmann, Felix Bachmann, Anne Schmitt-Hoffmann, Klaus Gebhardt, Jochen Spickermann, Claude Nuoffer, Gérard Biringer, Terence O'Reilly, Martin Pruschy, Heidi A. Lane
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1347.
https://doi.org/10.1158/1538-7445.AM2011-1347
Published: 15 April 2011
View article titled, Abstract 1347: BAL101553: An optimized prodrug of the microtubule destabilizer BAL27862 with superior antitumor activity
Journal Articles

Abstract 4419: BAL101553: A highly soluble prodrug of the potent microtubule destabilizer BAL27862

Jens Pohlmann, Felix Bachmann, Anne Schmitt-Hoffmann, Gérard Biringer, Karin Burger, Christian Bucher, Caroline Schlaefle, Martin Pruschy, Heidi Lane
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4419.
https://doi.org/10.1158/1538-7445.AM10-4419
Published: 15 April 2010
View article titled, Abstract 4419: BAL101553: A highly soluble prodrug of the potent microtubule destabilizer BAL27862
Journal Articles

Genomic demethylation enhances radiation sensitivity in colorectal carcinoma.

Ilja F. Ciernik, Christian Forrer, Barbara Hofstetter, Fredrik T. Bosman, Martin Pruschy, Jean Benhattar
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1213.
Published: 15 April 2006
View article titled, Genomic demethylation enhances radiation sensitivity in colorectal carcinoma.
Journal Articles

Differential Activation of the Phosphatidylinositol 3′-Kinase/Akt Survival Pathway by Ionizing Radiation in Tumor and Primary Endothelial Cells

Daniel Zingg, Oliver Riesterer, Doriano Fabbro, Christoph Glanzmann, Stephan Bodis, Martin Pruschy
Journal: Cancer Research
Cancer Res (2004) 64 (15): 5398–5406.
https://doi.org/10.1158/0008-5472.CAN-03-3369
Published: 02 August 2004
View article titled, Differential Activation of the Phosphatidylinositol 3′-Kinase/Akt Survival Pathway by Ionizing Radiation in Tumor and Primary Endothelial Cells
Open the PDF for Differential Activation of the Phosphatidylinositol 3′-Kinase/Akt Survival Pathway by Ionizing Radiation in Tumor and Primary Endothelial Cells in another window
Journal Articles

The Phosphatidylinositide 3′-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C

Angela Tenzer, Daniel Zingg, Sonia Rocha, Brian Hemmings, Doriano Fabbro, Christoph Glanzmann, P. August Schubiger, Stephan Bodis, Martin Pruschy
Journal: Cancer Research
Cancer Res (2001) 61 (22): 8203–8210.
Published: 01 November 2001
View article titled, The Phosphatidylinositide 3′-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C
Open the PDF for The Phosphatidylinositide 3′-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C in another window
Journal Articles

Differential p53-dependent Mechanism of Radiosensitization in Vitro and in Vivo by the Protein Kinase C-specific Inhibitor PKC412

Kathrin Zaugg, Sonia Rocha, Hildegard Resch, Ivan Hegyi, Christoph Oehler, Christoph Glanzmann, Doriano Fabbro, Stephan Bodis, Martin Pruschy
Journal: Cancer Research
Cancer Res (2001) 61 (2): 732–738.
Published: 01 January 2001
View article titled, Differential p53-dependent Mechanism of Radiosensitization <em>in Vitro</em> and <em>in Vivo</em> by the Protein Kinase C-specific Inhibitor PKC412
Open the PDF for Differential p53-dependent Mechanism of Radiosensitization <em>in Vitro</em> and <em>in Vivo</em> by the Protein Kinase C-specific Inhibitor PKC412 in another window